Microbot Medical Inc. in a continuation of its efforts to create barriers and expand its global intellectual property portfolio for the LIBERTY® Robotic System, was issued a design patent allowance by the US Patent & Trademark Office (USPTO), covering the LIBERTY Robotic System's remote controller unique interface design. The Company will be showcasing and demonstrating the LIBERTY Robotic System on January 9-11, 2023, in San Francisco, CA, concurrent with a leading healthcare conference.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9401 USD | -2.83% | +1.82% | -42.68% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.68% | 13.54M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- MBOT Stock
- News Microbot Medical Inc.
- Microbot Medical’s Novel LIBERTY® Robotic System Continues to be Validated with Latest U.S. Design Patent Allowance